Physician

Kerrin D Burte, MD

According to 2025 Medicare claims, Kerrin Burte, MD (NPI: 1336144567) practices rheumatology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Boone, KY. This provider's primary affiliated billing organization is TRISTATE ARTHRITIS & RHEUMATOLOGY PSC (NPI: 1851449425; TIN: 611104130) and primary practice location at 41017-2418. Burte is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Burte's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 196 traditional Medicare patients, billed 138,252 HCPCS/CPT codes, and received $1,420,995 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,548 prescription claims across 281 beneficiaries totaling $794,361 in drug costs, led by Enbrel Sureclick (Etanercept). 2019 DME data shows 22 claims. Open Payments data shows 111 records totaling $2,266. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	380	49,432	$945,526
2016	355	53,816	$1,072,783
2017	338	54,085	$1,210,021
2018	323	68,109	$1,411,224
2019	311	73,387	$1,311,603
2020	278	86,989	$1,415,956
2021	286	100,679	$1,461,385
2022	249	120,314	$1,367,539
2023	223	107,244	$1,673,695
2024	196	138,252	$1,420,995

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	364	3,085	$567,022
2016	339	3,302	$706,945
2017	361	3,446	$749,329
2018	352	3,356	$684,649
2019	339	3,203	$641,339
2020	340	3,242	$576,022
2021	341	3,206	$700,615
2022	307	2,998	$735,921
2023	275	2,839	$925,985
2024	281	2,548	$794,361

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	22	$760
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	57	476	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	184	545	$86
20611	Aspiration and/or injection of fluid large joint using ultrasound guidance	62	129	$71
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	148	349	$12
J1010	Injection, methylprednisolone acetate, 1 mg	91	20,820	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	22	616	$174,614
Rinvoq	Upadacitinib	14	480	$100,869
Humira(Cf) Pen	Adalimumab	13	364	$89,148
Percocet	Oxycodone Hcl/Acetaminophen	12	360	$77,420
Orencia Clickject	Abatacept	13	364	$72,852

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	111	$2,266	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kerrin D. Burte, MD?

Tedicare shows public-source Medicare data for Kerrin D. Burte, MD (NPI 1336144567), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kerrin D. Burte, MD have ACO affiliation data?

Kerrin D. Burte, MD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Kerrin D. Burte, MD?

Kerrin D. Burte, MD is linked to TRISTATE ARTHRITIS & RHEUMATOLOGY PSC (billing NPI 1851449425) in the available physician profile data.

Does Kerrin D. Burte, MD have Open Payments data?

Kerrin D. Burte, MD has 111 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.